HealthQuill FDA
Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid tumors.
Drugs Health Pharma

Canada’s Fusion gets FDA nod for drug tests to treat solid tumors

HQ Team April 13, 2023: Fusion Pharmaceuticals, a Canada-based radiopharmaceuticals company, announced FDA clearance for its investigational new drug applications to treat solid.

Read More
Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its relapsing multiple sclerosis drug after it caused liver injuries.
Drugs Health Pharma

FDA applies brakes on Merck’s multiple sclerosis drug tests

HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its.

Read More
Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for treating type 2 diabetes.
Drugs Health Medical Pharma

Cipla, Novartis team up to make, market anti-diabetic drug

HQ Team April 10, 2023: Cipla Ltd has agreed with Novartis Pharma AG to market and manufacture the Swiss-based company’s Galvus brand for.

Read More
The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove its benefits in clinical trials.
Drugs Health Medical Pharma

FDA withdraws approval for Covis’ preterm birth prevention drug

HQ Team April 7, 2023: The FDA has withdrawn Netherland-based Covis Pharma’s drug meant to cut preterm birth as it failed to prove.

Read More
BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer antibody drug candidates.
Drugs Medical Pharma

BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs

HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.

Read More
Photo by Kamila Maciejewska on Unsplash
Drugs Medical Pharma

Global Pharma recalls eye drops in US after ‘possible’ contamination

The CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states. 

Read More
US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.
Drugs Health Pharma

FDA clears Emergent’s nasal spray for opioid overuse to sell at pharmacies

US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.

Read More
ndia’s Technology Development Board has signed a pact with Huwel Lifesciences for the validation and commercialisation of rapid real-time PCR reagents for storage and transport at room temperature.
Drugs Medical Pharma

India inks pact with Huwel Lifesciences to make rapid real-time PCR reagents

ndia’s Technology Development Board has signed a pact with Huwel Lifesciences for the validation and commercialisation of rapid real-time PCR reagents for storage.

Read More
The US FDA plans to permit the use of salt substitutes in daily food, such as bread, cheeses and ketchup, to reduce the harmful effects of sodium intake that leads to heart attacks and strokes.
Drugs Health Pharma

FDA to permit salt substitutes to fight heart disease in US

The US FDA plans to permit the use of salt substitutes in daily food, such as bread, cheeses and ketchup, to reduce the.

Read More
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of GlaxoSmithKline.
Drugs Medical Pharma

Glenmark’s drug to treat nausea, psychosis gets FDA nod

India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of.

Read More